Inovio Pharmaceuticals Ratios (2010-2025) | INO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)	-14,541.86%	-30,107.31%	-20,627.17%	-12,745.28%	-38,633.12%	-13,831.97%	-412.75%	-43,687.24%	-35,364.76%	-15,725.26%	-8,734.77%	-24,357.91%		-31,648.39%		-16,682.03%	-37,100.30%
EBIT Margin (Quarter)	-14,161.05%	-30,496.56%	-20,553.16%	-12,573.76%	-36,033.33%	-13,276.13%	-390.61%	-44,876.83%	-38,238.24%	-16,391.97%	-9,152.63%	-26,686.29%		-32,945.87%		-17,410.77%	-38,336.97%
EBITDA Margin (Quarter)	-14,161.05%	-30,496.56%	-20,553.16%	-12,573.76%	-36,033.33%	-13,276.13%	-390.61%	-44,876.83%	-38,238.24%	-16,391.97%	-9,152.63%	-26,686.29%		-32,945.87%		-17,410.77%	-38,336.97%
Operating Margin (Quarter)	-14,161.05%	-30,496.56%	-20,553.16%	-12,573.76%	-36,033.33%	-13,276.13%	-390.61%	-44,876.83%	-38,238.24%	-16,391.97%	-9,152.63%	-26,686.29%		-32,945.87%		-17,410.77%	-38,336.97%
Net Margin (Quarter)	-14,541.86%	-30,107.31%	-20,627.17%	-12,745.28%	-38,633.12%	-13,831.97%	-412.75%	-43,687.24%	-35,364.76%	-15,725.26%	-8,734.77%	-24,357.91%		-31,648.39%		-16,682.03%	-37,100.30%
FCF Margin (Quarter)	-14,302.18%	-28,834.39%	-15,804.38%	-4,536.55%	-31,251.13%	-6,408.10%	-745.04%	-28,591.73%	-32,156.34%	-14,310.94%	-7,494.13%	-25,597.20%		-28,040.54%		-16,807.62%	-41,127.63%
Efficiency
Assets Average (Quarter)	597.32M	623.35M	563.80M	515.85M	470.73M	452.46M	425.68M	370.25M	307.56M	249.81M	213.07M	182.02M	150.03M	131.46M	120.43M	110.13M	100.23M	77.76M	68.81M	71.85M
Equity Average (Quarter)	521.37M	545.08M	481.06M	426.62M	377.38M	326.38M	282.18M	244.53M	210.79M	184.29M	153.77M	127.75M	105.90M	95.59M	85.14M	71.02M	59.88M	39.89M	10.41M	8.19M
Invested Capital (Quarter)	582.37M	510.33M	454.06M	400.22M	356.49M	299.01M	268.33M	222.36M	200.63M	186.08M	154.65M	117.35M	94.44M	96.74M	73.54M	81.76M	60.79M	39.95M	42.66M	53.16M
Asset Utilization Ratio (Quarter)	0.01	0.01	0.01	0.00	0.00	0.00	0.03	0.03	0.03	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-102.44	-178.27	-125.85	-219.67	-228.82	-332.19	-114.06	-178.46	-140.20	-118.16	-113.41	-97.03	-177.05
Debt to Equity (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	0.01		0.01	0.10	0.12					0.19	0.19	0.40	-6.53	1.21
Debt Ratio (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.01	0.07	0.09					0.12	0.11	0.17	0.73	0.39
Equity Ratio (Quarter)	0.89	0.86	0.85	0.81	0.80	0.65	0.68	0.64	0.75	0.73	0.72	0.69	0.73	0.72	0.69	0.61	0.59	0.42	-0.11	0.32
Times Interest Earned (Quarter)	-102.44	-178.27	-125.85	-219.67	-228.82	-332.19	-114.06	-178.46	-140.20	-118.16	-113.41	-97.03	-177.05
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-518.60M	-443.68M	-394.94M	-401.31M	-360.39M	-348.13M	-281.88M	-253.00M	-223.75M	-194.93M	-167.47M	-145.29M	-105.61M	-110.42M	-84.80M	-67.43M	-68.36M	-47.55M	-50.80M	-58.51M
Return Ratios
Return on Sales (Quarter)	-145.42%	-301.07%	-206.27%	-127.45%	-386.33%	-138.32%	-4.13%	-436.87%	-353.65%	-157.25%	-87.35%	-243.58%	-173.81%	-316.48%	-556.98%	-166.82%	-371.00%	-507.16%	-476.54%	-1,291.68%
Return on Capital Employed (Quarter)	-0.27%	-0.35%	-0.44%	-0.67%	-0.78%	-1.06%	-0.96%	-0.98%	-0.95%	-0.87%	-1.02%	-1.03%	-1.04%	-1.21%	-1.23%	-1.50%	-1.45%	-2.08%	88.76%	-3.08%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	-0.31%	-0.22%	-0.39%	-0.59%	-0.69%	-0.78%	-0.78%	-0.75%	-0.78%	-0.67%	-0.77%	-0.74%	-0.83%	-0.92%	-0.94%	-0.98%	-1.02%	-1.19%	-1.26%	-1.17%
Return on Equity (Quarter)	-0.35%	-0.25%	-0.45%	-0.71%	-0.86%	-1.08%	-1.17%	-1.14%	-1.15%	-0.91%	-1.07%	-1.06%	-1.18%	-1.27%	-1.33%	-1.52%	-1.70%	-2.32%	-8.35%	-10.31%

Research Tools

Inovio Pharmaceuticals Ratios (2010-2025) | INO

Create an account

Sign In

Reset Password